HNN3.0
Register
Register
Register

University of Applied Sciences, Berne (BFH)

University

www.bfh.ch/en/Berne, Switzerland
9 profile visits

Representatives

Professor/Lecturer

University of Applied Sciences, Berne (BFH)

Professor

University of Applied Sciences, Berne (BFH)

Marketplace (2)

  • Project cooperation

    Human and Child-centered Design and Responsible AI Use

    As WP or task leads, we contribute human-centred design, participatory design, and the ethics of AI. Through our ongoing experience as a coordinator in a Horizon Europe THRIVE, we contribute youth research, user engagement and SSH partnership.

    • Destination 5: HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
    • Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
    Author

    Professor at University of Applied Sciences, Berne (BFH)

    Bern, Switzerland

  • Project cooperation

    Looking to join as consortium as former health-tech (incl. AI) CEO

    I build and lead a digital health company as CEO, where we provided an AI-based digital therapeutic for people suffering from chronic skin conditions, based on my own history with eczema/atopic dermatitis. Today, I am a lecturer at BFH / Swiss university.

    • Partner seeks Consortium/Coordinator
    • Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
    • Destination 5: HORIZON-HLTH-2027-03-TOOL-08: Towards the next generation of frontier Artificial Intelligence models for healthcare
    • Destination 1: HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
    • Destination 5: HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
    • Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
    • Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
    • Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
    Author

    Professor/Lecturer at University of Applied Sciences, Berne (BFH)

    Zurich, Switzerland